Iain Wilcock

Investment Advisor

2008 - Current

On going UK and Irish Healthcare Investment Advisor. Board roles include; FIRE1, Microbiotica, ArGEN-X, Kebony, Push Doctor. Notable exits ArGEN-X IPO, BiancaMed acquired by ResMed.

Managing Director

2015

Founder, Director

2007

He has worked with several venture capital funds on a variety of assignments since leaving Quester included advising on fund raising, deal origination, due diligence and execution. Currently he is retained by Seventure Partners, a Paris based VC and NESTA, a UK early stage investor.

Investment Director

2008 - 2010

Sourced new Healthcare investments and was responsible for the Healthcare portfolio. Notable exits: Sirigen and Dexela. This role was carried out alongside other roles, such as with Seventure and Strategic Advisory Board for Intellectual Property

Chairman Of The Board

2005 - 2008

Deputy Managing Director

1996 - 2007

As Deputy Managing Director, He was responsible for all aspects of fund management. Iain founded the Healthcare investment practise and the university linked deal origination platform. When he joined Quester it had under £20m under management and only 4 employees. When Quester was sold in 2007, it had approximately £250m under management and an investment team of 10. Notable exits: Glycart, Vivacta, Sterix, Avidex, Mirada, PowderMed.

Senior Manager

1988 - 1995

As a Senior Manager in the corporate finance department he gained experience of a wider range of transactions including mergers, acquisitions, IPO's, disposals and insolvency. He also qualified as a tax specialist which helps with the structuring and modeling of many transactions.